<DOC>
	<DOC>NCT01238679</DOC>
	<brief_summary>This study aims to assess the safety, tolerability, and pharmacokinetics of PF-04958242 at a number of ascending doses administered for 14 days in healthy volunteers.</brief_summary>
	<brief_title>Multiple Dose Tolerance Study For PF-04958242</brief_title>
	<detailed_description>A decision was made to terminate the B1701002 study so that emerging data from the study and from a preclinical study in rats could be further examined and incorporated into a new study design and protocol.</detailed_description>
	<criteria>males or females of nonchildbearing capacity No medical, neurological or psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>healthy volunteers</keyword>
</DOC>